Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 601–700 of 1,003
Wang, X., Ma, C., Wu, J., & Zhu, J. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23233 · Cited by 52
“It has been shown that Th17 cells are able to cross the BBB, which facilitates the infiltration of inflammatory cells (Kebir et al., 2007).”
BackgroundThe role of T helper subsets in autoimmunity and allergy
Veldhoen, M. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.009 · Cited by 55
Bhela, S., Kempsell, C., Manohar, M., Dominguez-Villar, M., Griffin, R., Bhatt, P., Kivisakk-Webb, P., Fuhlbrigge, R., Kupper, T., Weiner, H., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1303257 · Cited by 49
“found in CNS plaques in patients with MS (25) and in the synovial fluid of patients with RA (26), whereas an allele of GzmB increases risk for vitiligo (27).”
BackgroundPET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis
Liu, H., Jin, H., Yue, X., Luo, Z., Liu, C., Rosenberg, A. J., & Tu, Z. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0944-y · Cited by 52
“This observation was consistent with the findings in MS patients [36, 37].”
ResultZhang, H., Qi, Y., Yuan, Y., Cai, L., Xu, H., Zhang, L., Su, B., & Nie, H. (2017) · Scientific Reports · doi:10.1038/srep41887 · Cited by 50
Kumar, P., Chan, D. W. S., Lim, A. J. M., Paleja, B. S., Ling, S. R., Yun, L. L., Poh, S. L., Ngoh, A. S. F., Arkachaisri, T., Yeo, J. G., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126337 · Cited by 50
“IL-17 helps permeabilize the human blood-brain barrier to soluble molecules and circulating CD4+ lymphocytes, and GZMB+ Th17 cells exert cytolytic activity on human fetal neurons (18).”
BackgroundMethodThe Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
Maglione, A., Rolla, S., Mercanti, S. F. D., Cutrupi, S., & Clerico, M. (2019) · Cells · doi:10.3390/cells8101280 · Cited by 54
Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
Negron, A., Stüve, O., & Forsthuber, T. G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.607766 · Cited by 47
“Both IL-17 and IL-22, which are produced by TH17 cells, facilitate BBB disruption and potentially induce the production of CXCL13 by meningeal stromal cells (111, 112, 125, 184).”
BackgroundJanus‐like effects of type I interferon in autoimmune diseases
Axtell, R. C., & Raman, C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01131.x · Cited by 47
Interferon-γ Safeguards Blood-Brain Barrier during Experimental Autoimmune Encephalomyelitis
Chen, N., Wang, C., Zhang, J., Qu, L.-W., Liu, X., Lu, Y., Yang, W. C., Deng, J., Lorenz, D., Gao, P., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.019 · Cited by 53
“In addition, interleukin-17 (IL-17) Q also diminishes the expression of ZO-1 and OCLN.(11) It has been demonstrated that the BBB disruption”
BackgroundInfluentialMa, S., Zhong, D., Chen, H., Zheng, Y., Sun, Y., Luo, J., Li, H., Li, G., & Yin, Y. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.01.007 · Cited by 47
“Other studies also showed that IL-17 could promote blood–brain barrier disruption and central nervous system inflammation (Kebir et al., 2007).”
BackgroundThe Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
Vojdani, A., Lambert, J., & Kellermann, G. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/nep064 · Cited by 47
Lam, L., Chin, L., Halder, R. C., Sagong, B., Famenini, S., Sayre, J. W., Montoya, D. J., Rubbi, L., Pellegrini, M. A., & Fiala, M. (2016) · The FASEB Journal · doi:10.1096/fj.201600259rr · Cited by 50
“Immunopathologic mechanisms include phagocytosis of apoptotic and nonapoptotic neurons by inflammatory macrophages (29), toxicity induced by granzyme-positive CD8 T cells (30), disruption of the blood–brain barrier by Th17 cells (31), and IL-6 trans-signaling (demonstrated to be toxic in a dose-related fashion in the…”
BackgroundO’Connell, G. C., Treadway, M. B., Petrone, A. B., Tennant, C. S., Lucke-Wold, N., Chantler, P. D., & Barr, T. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-01178-5 · Cited by 47
Exploring Non-Metabolic Functions of Glycolytic Enzymes in Immunity
Seki, S. M., & Gaultier, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01549 · Cited by 48
Acharya, S., Timilshina, M., Jiang, L., Neupane, S., Choi, D., Park, S., Lee, S. Y., Jeong, B., Kim, J., Nam, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26088-y · Cited by 51
Interleukin-26, preferentially produced by T H 17 lymphocytes, regulates CNS barrier function
Broux, B., Zandee, S., Gowing, E., Charabati, M., Lécuyer, M., Tastet, O., Hachehouche, L., Bourbonnière, L., Ouimet, J.-P., Lemaître, F., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000870 · Cited by 49
Self-citationMorgan, B. P., Gommerman, J. L., & Ramaglia, V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.600656 · Cited by 59
“In addition to CD8 T cells, CD4 T cells are also found in MS lesions and have been shown to produce cytokines such as IL-17 and IL-22 which possibly bind to BBB endothelial cells expressing IL-17 and IL-22 receptors, thereby gaining access to the CNS parenchyma (Kebir et al., 2007).”
BackgroundAhmad, S. F., Zoheir, K. M. A., Abdel‐Hamied, H. E., Attia, S. M., Bakheet, S. A., Ashour, A. E., & Abd‐Allah, A. R. A. (2013) · Inflammation · doi:10.1007/s10753-013-9764-2 · Cited by 47
“its expression has been reported to increase in autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and psoriasis in humans [6, 7] as well as in animal models of autoimmunity [8].”
BackgroundBachmann, M., Horn, K., Rudloff, I., Goren, I., Holdener, M., Christen, U., Darsow, N., Hunfeld, K., Koehl, U., Kind, P., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001144 · Cited by 50
“Indeed, IL-22 has been shown to increase vascular permeability [73], a function that may relate to upregulation of matrix metalloproteinases [13,74–76] and iNOS [17,77] under the influence of this cytokine.”
BackgroundThe role of iron metabolism in the pathogenesis and treatment of multiple sclerosis
Duarte-Silva, E., Meuth, S. G., & Peixoto, C. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1137635 · Cited by 46
“For instance, it is known that IL-17 and IL-22 secreted by Th17 cells cause increased permeability in the bloodbrain-barrier (BBB), which allows them to migrate into the brain parenchyma and initiate disease (18).”
BackgroundTang, S., Fan, X., Pan, Q.-M., Sun, Q., & Liu, Y. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.11.035 · Cited by 49
“Furthermore, IL-17 production in CNS-infiltrating T cells was shown to be associated with blood-brain barrier destruction and disease activity [39, 40].”
BackgroundAstrocytopathy in Baló’s disease
Kira, J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511400475 · Cited by 50
“Increasing evidence suggests that Th17 cells, but not Th1 cells, are responsible for organ-specific autoimmune diseases such as EAE.58,59 Th17 cells carrying granzyme B have recently been shown to efficiently disrupt BBB tight junctions and loosen the BBB.60 Therefore, autoimmune Th17 cells may initiate BBB disruption…”
BackgroundLiao, C., Liou, A.-T., Chang, Y., Wu, S.-Y., Chang, C.-S., Lee, C., Kung, J. T., Tu, P., Yu, Y., Lin, C., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00692-14 · Cited by 47
“IL-17, detected in the spinal cord (Table 1), has been reported to influence the permeability of the blood-brain barrier (42).”
BackgroundChen, S., Wang, A. Y. L., Fan, H., Lo, W., Wang, C., & Sytwu, H. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/970789 · Cited by 47
“These Th17 cells transmigrate efficiently across BBB endothelial cells (BBB-ECs), leading to the destruction of human neurons and initiating CNS inflammation through Th-cell recruitment [70] .”
BackgroundSerafini, B., Rosicarelli, B., Veroni, C., Zhou, L., Reali, C., & Aloisi, F. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw063 · Cited by 45
Muls, N., Nasr, Z., Dang, H. A., Sindic, C., & Pesch, V. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173780 · Cited by 49
Association of T and non-T cell cytokines with anhedonia: Role of gender differences
Jha, M. K., Miller, A. H., Minhajuddin, A., & Trivedi, M. H. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.017 · Cited by 47
“Additionally, while the role of IL-17 in disruption of blood-brain barrier is well recognized (Huppert et al., 2010; Kebir et al., 2007), the ratio of Th17 to Th1 cells is considered critical in the infiltration of brain parenchyma by peripheral immune cells and subsequent neuroinflammation (Stromnes et al.”
BackgroundIL-23 in Infections, Inflammation, Autoimmunity and Cancer: Possible Role in HIV-1 and AIDS
Yannam, G. R., Gutti, T. L., & Poluektova, L. Y. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9315-2 · Cited by 54
“In addition, IL-23-stimulated peripheral blood CD4+ lymphocytes are potentially efficient at penetrating brain derived microvascular endothelial monolayers in vitro (Kebir et al. 2007).”
BackgroundTH Cells and Cytokines in Encephalitogenic Disorders
Krishnarajah, S., & Becher, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.822919 · Cited by 55
“Evidence links IL-17 with barrier function in other organs such as the lung and gut (48, 49), with further experimental data pointing towards IL-17 playing a role in altering of the neurovascular junction being convincing (50, 51).”
BackgroundSelf-citationAlzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition
Cariddi, L. P., Mauri, M. F., Cosentino, M., Versino, M., & Marino, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113008 · Cited by 47
“and IL-17 or release of granzyme B [129,130].”
BackgroundCharabati, M., Zandee, S., Fournier, A. P., Tastet, O., Thai, K., Zaminpeyma, R., Lécuyer, M., Bourbonnière, L., Larouche, S., Klément, W., et al. (2022) · Brain · doi:10.1093/brain/awac389 · Cited by 56
Self-citationCosentino, M., Zaffaroni, M., Trojano, M., Giorelli, M., Pica, C., Rasini, E., Bombelli, R., Ferrari, M., Ghezzi, A., Comi, G., et al. (2012) · NeuroImmunoModulation · doi:10.1159/000336981 · Cited by 45
Which drug or drug delivery system can change clinical practice for brain tumor therapy?
Siegal, T. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not016 · Cited by 47
Grygorczuk, S., Świerzbińska, R., Kondrusik, M., Dunaj, J., Czupryna, P., Moniuszko-Malinowska, A. M., Siemieniako, A., & Pancewicz, S. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1138-0 · Cited by 47
“In animal experiments, CXCR2 signaling contributes to the neutrophil migration from the bone marrow into blood under stress stimuli [62] and IL-22 causes neutrophilia mediated by CXCL1 release from hepatocytes [37, 43], and similar mechanisms could play a role in neutrophil mobilization and migration in TBE patients,…”
Anti-inflammatory effects of dietary vitamin D 3 in patients with multiple sclerosis
Hashemi, R., Morshedi, M., Jafarabadi, M. A., Altafi, D., Hosseini-Asl, S. S., & Arefhosseini, S. R. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000278 · Cited by 52
“Specially, IL-17A plays a significant role in the stimulation and secretion of proinflammatory cytokines and in chronic CNS inflammation.(4,5)”
BackgroundBronge, M., Ruhrmann, S., Carvalho‐Queiroz, C., Nilsson, O. B., Kaiser, A., Holmgren, E., Macrini, C., Winklmeier, S., Meinl, E., Brundin, L., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.013 · Cited by 45
Glial Cells as Regulators of Neuroimmune Interactions in the Central Nervous System
Antel, J. P., Becher, B., Ludwin, S. K., Prat, A., & Quintana, F. J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900908 · Cited by 47
Self-citationIdentification of Novel Molecular Markers of Human Th17 Cells
Sałkowska, A., Karaś, K., Karwaciak, I., Walczak‐Drzewiecka, A., Krawczyk, M., Sobalska‐Kwapis, M., Dastych, J., & Ratajewski, M. (2020) · Cells · doi:10.3390/cells9071611 · Cited by 47
“However, despite their important physiological role in humans, Th17 cells are known mainly for their negative role over the course of numerous autoimmune diseases, including rheumatoid arthritis [17], multiple sclerosis [18], psoriasis [19], inflammatory bowel disease [20], Graves’ disease [21], ankylosing spondylitis…”
BackgroundRegulatory role of resveratrol on Th17 in autoimmune disease
Petro, T. M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.07.011 · Cited by 45
Multiple Sclerosis and Autoimmunity: A Veiled Relationship
Barkhane, Z., Elmadi, J., Kumar, L. S., Pugalenthi, L. S., Ahmad, M., & Reddy, S. (2022) · Cureus · doi:10.7759/cureus.24294 · Cited by 50
“Th17 cells, which cause MS [75-80], are also linked to RA since they generate proinflammatory cytokines like IL-6 and facilitate matrix metalloproteinase synthesis by synovial fibroblasts [81].”
BackgroundVellecco, V., Saviano, A., Raucci, F., Casillo, G. M., Mansour, A. A., Panza, E., Mitidieri, E., Femminella, G. D., Ferrara, N., Cirino, G., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106595 · Cited by 49
The role of T cells in acute ischemic stroke
Wang, Y.-R., Cui, W., Wu, H., Xu, X., & Xu, X.-Q. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.03.005 · Cited by 48
Bharadwaj, A. S., Schewitz‐Bowers, L. P., Wei, L., Lee, R., & Smith, J. R. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12058 · Cited by 44
“Although the T cells are derived from healthy adult humans, polarization yields populations that are relevant for the study of human autoimmune disease.(25) By the first method, human CD4þ CCR6 or CCR6þ T cells were exposed to rhIL-12 and anti-IL-4 Ab, or rhIL-1b, rhIL-6, rhIL-23, anti-IFN-c Ab, and anti-IL-4 Ab, in t…”
InfluentialMardiguian, S., Serres, S., Ladds, E. C., Campbell, S. J., Wilainam, P., McFadyen, C., McAteer, M. A., Choudhury, R. P., Smith, P., Saunders, F., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.029 · Cited by 47
INTERLEUKIN-22 DETECTED IN PATIENTS WITH ABDOMINAL SEPSIS
Bingold, T. M., Ziesché, E., Scheller, B., Sadik, C. D., Franck, K., Just, L., Sartorius, S., Wahrmann, M., Wissing, H., Zwißler, B., et al. (2010) · Shock · doi:10.1097/shk.0b013e3181dc07b1 · Cited by 43
“host defense (1, 2, 19, 20), immunosuppression (4), and a proinflammatory deleterious potential (2, 7, 8, 23, 24).”
BackgroundIshii, H., Jin, X., Ueno, M., Tanabe, S., Kubo, T., Serada, S., Naka, T., & Yamashita, T. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.106 · Cited by 54
“IFN-g-producing type 1 helper T (Th1) cells and IL-17-producing helper T (Th17) cells are associated with the disease onset and progression of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis.(17) Shift to IL-4-producing type 2 helper T (Th2) cells was suggested to lead to enhance…”
BackgroundCurrent and future disease-modifying therapies in multiple sclerosis
Lim, S., & Constantinescu, C. S. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02261.x · Cited by 58
The Role of IL-17A in Mediating Inflammatory Responses and Progression of Neurodegenerative Diseases
Zheng, M., & Luo, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062505 · Cited by 49
“These effects have been validated in vitro using human and mouse BBB models [59].”
Competition between colitogenic Th1 and Th17 cells contributes to the amelioration of colitis
Mikami, Y., Kanai∥, T., Sujino, T., Ono, Y., Hayashi, A., Okazawa, A., Kamada, N., Matsuoka, K., Hisamatsu, T., Okamoto, S., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040379 · Cited by 43
Venken, K., Hellings, N., Hensen, K., Rummens, J., & Stinissen, P. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.025 · Cited by 43
“The pathogenic role of Th17 cells was further demonstrated by their capacity to kill human neuron cells in vitro (Kebir et al., 2007).”
BackgroundResultInfluentialWang, Y., Cao, L., Xu, L., Cao, F., Peng, B., Zhang, X., Shen, Y.-F., Uzan, G., & Zhang, D. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9598-9 · Cited by 44
EGFL7 reduces CNS inflammation in mouse
Larochelle, C., Uphaus, T., Broux, B., Gowing, E., Paterka, M., Michel, L., Stanković, N. D., Bicker, F., Lemaître, F., Prat, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03186-z · Cited by 45
Self-citationAhmad, S. F., Nadeem, A., Ansari, M. A., Bakheet, S. A., Alshammari, M. A., & Attia, S. M. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.09.006 · Cited by 46
“IL-17A contributes to multiple sclerosis and EAE diseases (Kebir et al., 2007).”
Linker, R. A., & Lee, D.-H. (2009) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-1-5 · Cited by 43
Zhu, C.-L., Xie, J., Liu, Q., Wang, Y., Li, H.-R., Yu, C.-M., Li, P., Deng, X.-M., Bian, J.-J., & Wang, J.-F. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79913 · Cited by 42
Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis
Kunkl, M., Amormino, C., Tedeschi, V., Fiorillo, M. T., & Tuosto, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824411 · Cited by 52
Kerkering, J., Muinjonov, B., Rosiewicz, K. S., Diecke, S., Biese, C., Schiweck, J., Chien, C., Zocholl, D., Conrad, T., Paul, F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164637 · Cited by 41
Voltage-gated potassium channel 1.3: A promising molecular target in multiple disease therapy
Cheng, S., Jiang, D., Lan, X., Liu, K., & Fan, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116651 · Cited by 45
The T‐cell pool is anergized in patients with multiple sclerosis in remission
Fransson, M. E., Liljenfeldt, L. S. E., Fagius, J., Tötterman, T. H., & Loskog, A. S. I. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02881.x · Cited by 42
Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease
Rasouli, M., Heidari, B., & Kalani, M. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.09.017 · Cited by 43
Strategies for enhancing antibody delivery to the brain
Frank, R. T., Aboody, K. S., & Najbauer, J. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.002 · Cited by 48
Zubcevic, J. A., Santisteban, M. M., Pérez, P. D., Arocha, R., Hiller, H., Malphurs, W. L., Colón-Pérez, L. M., Sharma, R. K., de Kloet, A. D., Krause, E. G., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00592 · Cited by 44
“…important factor in compromising blood brain barrier (BBB) in HTN, as specific cell types and their associated cytokines, such as IL17, which are known to be increased in HTN (Madhur et al., 2010; Amador et al., 2014), have been implicated in BBB damage (Kebir et al., 2007; Huppert et al., 2010).”
BackgroundSleep Disruption and Cancer: Chicken or the Egg?
Berisha, A., Shutkind, K., & Borniger, J. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.856235 · Cited by 48
“Disrupted sleep patterns in breast cancer are also evidenced by alterations in the rhythmic secretion of cortisol, which is regulated by the central circadian clock in the suprachiasmatic nuclei (SCN) (Buijs et al., 2003; Abercrombie et al., 2004; Kiessling et al., 2017).”
BackgroundAltered blood–brain barrier transport in neuro-inflammatory disorders
Schenk, G. J., & de Vries, H. E. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.002 · Cited by 49
Distinct Cellular Tropism and Immune Responses to Alphavirus Infection
Kafai, N. M., Diamond, M., & Fox, J. M. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-014952 · Cited by 43
Basophils beyond allergic and parasitic diseases
Poto, R., Loffredo, S., Marone, G., di Salvatore, A., de Paulis, A., Schroeder, J. T., & Varricchi, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1190034 · Cited by 44
Increased Expression of IL-22 Is Associated with Disease Activity in Behcet’s Disease
Cai, T., Wang, Q., Zhou, Q., Wang, C., Hou, S., Qi, J., Kijlstra, A., & Yang, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059009 · Cited by 41
“[26] These results suggest a possible involvement of IL-22 in the pathophysiology of vessel inflammation.”
BackgroundInterferon-γ blocks signalling through PDGFRβ in human brain pericytes
Jansson, D., Scotter, E. L., Rustenhoven, J., Coppieters, N., Smyth, L. C. D., Oldfield, R. L., Bergin, P., Mee, E. W., Graham, E. S., Faull, R. L. M., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0722-4 · Cited by 48
Kong, Y., Wang, Y.-T., Cao, X.-N., Song, Y., Chen, Y., Sun, Y., Wang, Y., Zhang, X., Xu, L., & Huang, X. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1159-y · Cited by 41
“It has been determined that Th17 cells play a role in inflammation and autoimmune disease [19, 20].”
BackgroundSivri, R. Ç., Bilgiç, A., & Kılınç, İ. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1099-3 · Cited by 43
Steroids in Stroke with Special Reference to Progesterone
Guennoun, R., Zhu, X., Fréchou, M., Gaignard, P., Slama, A., Lière, P., & Schumacher, M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0627-0 · Cited by 41
Gadolinium and Multiple Sclerosis: Vessels, Barriers of the Brain, and Glymphatics
Saade, C., Bou‐Fakhredin, R., Yousem, D. M., Asmar, K., Naffaa, L. N., & El‐Merhi, F. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5773 · Cited by 50
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions
Melnikov, M., Rogovskii, V., Boyко, A., & Pashenkov, M. V. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09852-3 · Cited by 43
Th17 Cells in Viral Infections—Friend or Foe?
Paiva, I. A., Badolato-Corrêa, J., Familiar-Macedo, D., & de‐Oliveira‐Pinto, L. M. (2021) · Cells · doi:10.3390/cells10051159 · Cited by 45
“Blood–brain barrier (BBB) dysfunction with increased endothelial permeability is another important feature in MS [159].”
BackgroundCocktail Blood Biomarkers: Prediction of Clinical Outcomes in Patients with Acute Ischemic Stroke
Zeng, L., Liu, J., Wang, Y., Wang, L., Weng, S., Chen, S., & Yang, G. (2012) · European Neurology · doi:10.1159/000342896 · Cited by 47
Han, R. K., Cheng, Y. F., Zhou, S., Guo, H., He, R., Jun, L., & Zhang, L. M. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9965-3 · Cited by 44
IL-17 Signaling-Independent Central Nervous System Autoimmunity Is Negatively Regulated by TGF-β
González-García, I., Zhao, Y., Ju, S., Gu, Q., Liu, L., Kolls, J. K., & Lu, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802221 · Cited by 42
“These functions may include their abilities to induce chemokine production and to cause disruption of tight junctions of blood-brain barrier endothelial cells (2, 38, 39).”
BackgroundDexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo
Ziesché, E., Scheiermann, P., Bachmann, M., Sadik, C. D., Hofstetter, C., Zwissler, B., Pfeilschifter, J., & Mühl, H. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03969.x · Cited by 40
The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis
Burke, M. R., Sotiropoulos, I., & Waites, C. L. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.08.015 · Cited by 46
Cencicchio, M. A., Montini, F., Palmieri, V., Massimino, L., Nobili, A., Conte, M. L., Finardi, A., Mandelli, A., Asnicar, F., Pavlovic, R., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102028 · Cited by 56
Harnessing the Therapeutic Potential of Th17 Cells
Byström, J., Taher, T. E. I., Muhyaddin, M. S., Clanchy, F. I. L., Mangat, P., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/205156 · Cited by 49
“The cells have also been suggested to have a role in disruption of the blood brain barrier in multiple sclerosis (Figure 2(c)) [19, 20, 85].”
BackgroundLi, X., Liu, Y., Cao, L., Li, H., Yue, L.-T., Wang, S., Zhang, M., Li, X.-H., Dou, Y., & Duan, R. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.03.005 · Cited by 46
Liu, Y., Gibson, S. A., Benveniste, E. N., & Qin, H. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016015517 · Cited by 43
Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale
Karussis, D. M., & Petrou, P. (2018) · Immunologic Research · doi:10.1007/s12026-018-9032-5 · Cited by 42
Immunologic Aspects of Multiple Sclerosis
Boppana, S., Huang, H., Ito, K., & Dhib-Jalbut, S. S. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20249 · Cited by 40
Counter-regulation of T cell effector function by differentially activated p38
Alam, M. S., Gaida, M. M., Ogawa, Y., Kolios, A. G. A., Lasitschka, F., & Ashwell, J. D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131917 · Cited by 40
“Moreover, why TCR signaling utilizes a unique pathway, and not the conventional MAP kinase cascade (as it does for the MAPK ERK, for example; Koike et al., 2003) is an unanswered question.”
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO)
Vaknin-Dembinsky, A., Brill, L., Kassis, I., Petrou, P., Ovadia, H., Ben-Hur, T., Abramsky, O., & Karussis, D. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.12.004 · Cited by 39
wSDTNBI: a novel network-based inference method for virtual screening
Wu, Z., Ma, H., Liu, Z., Zheng, L., Yu, Z., Cao, S., Fang, W., Wu, L., Li, W., Liu, G., et al. (2021) · Chemical Science · doi:10.1039/d1sc05613a · Cited by 44
Pandey, M. K. (2023) · Biomedicines · doi:10.3390/biomedicines11041067 · Cited by 44
Joshi, P., Bisht, A., Joshi, S., Semwal, D. K., Nema, N. K., Dwivedi, J., & Sharma, S. K. (2022) · Phytotherapy Research · doi:10.1002/ptr.7522 · Cited by 41
“Subsequently, curcumin is reported to inhibit TNF-α induction that further reduces ZO-1 activity in HCE cells.”
BackgroundInfluentialMultiple Sclerosis and the Blood-Central Nervous System Barrier
Palmer, A. M. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/530356 · Cited by 49
Autoimmune diseases in the TH17 era
Mesquita, D., Jr., Cruvinel, W. M., Câmara, N. O. S., Kallas, E. G., & Andrade, L. E. C. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009000600002 · Cited by 48
Type 3 cytokines in liver fibrosis and liver cancer
Molina, M. F., Abdelnabi, M. N., Fabre, T., & Shoukry, N. H. (2018) · Cytokine · doi:10.1016/j.cyto.2018.07.028 · Cited by 44
miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases
Huang, J., Xu, X., & Yang, J. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.593473 · Cited by 43
“As IL-17 and IL-22 disrupt tight junction proteins in CNS endothelial cells (74, 75), activated Th17 cells freely migrate through the blood-brain barrier into MS lesions (76).”
BackgroundRole of alarmins in poststroke inflammation and neuronal repair
Sakai, S., & Shichita, T. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00961-5 · Cited by 43
CXCR3-Expressing T Cells in Infections and Autoimmunity
Rubinstein, A., Kudryavtsev, I. V., Arsentieva, N. A., Korobova, Z. R., Isakov, D., & Тотолян, А. А. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2908301 · Cited by 48
“1 cells efficiently transmigrate in vitro through the endothelium found in the blood-brain barrier [222].”
Zainab, S. R., Khan, J., Tipu, M. K., Jahan, F., & Irshad, N. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.029 · Cited by 45
Murta, V., & Ferrari, C. C. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.06.004 · Cited by 41
“BBB permeability and promotes lymphocyte and monocyte migration (Kebir et al., 2007).”
Bălașa, R., Bajkó, Z., & Huţanu, A. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512468497 · Cited by 47
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.